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Abstract
Background:  The inappropriate use of anabolic androgenic steroids (AAS) was originally a
problem among athletes but AAS are now often used in nonsport situations and by patients
attending regular addiction clinics. The aim of this study was to improve understanding of the
development of multiple drug use in patients seeking treatment at an addiction clinic for AAS-
related problems.
Methods: We interviewed six patients (four men and two women) with experience of AAS use
who were attending an addiction clinic for what they believed were AAS-related problems. The
patients were interviewed in-depth about their life stories, with special emphasis on social
background, substance use, the development of total drug use and subjective experienced
psychological and physical side effects.
Results: There was significant variation in the development of drug use in relation to social
background, onset of drug use, relationship to AAS use and experience of AAS effects. All patients
had initially experienced positive effects from AAS but, over time, the negative experiences had
outweighed the positive effects. All patients were dedicated to excess training and took AAS in
combination with gym training, indicating that the use of these drugs is closely related to this form
of training. Use of multiple drugs was common either in parallel with AAS use or serially.
Conclusion: The study shows the importance of understanding how AAS use can develop either
with or without the concomitant use of other drugs of abuse. The use of AAS can, however,
progress to the use of other drugs. The study also indicates the importance of obtaining accurate,
comprehensive information about the development of AAS use in designing treatment programmes
and prevention strategies in this area.
Background
Anabolic androgenic steroids (AAS) are synthetic deriva-
tives of the male endogenous sex hormone testosterone,
which exhibits both anabolic (protein-synthesizing) and
androgenic (masculinizing) effects. These drugs were orig-
inally used only in the context of elite sports [1]. Today,
however, AAS are used by a far wider range of groups out-
side of sports and athletics [2,3]. The use of AAS has there-
fore become a subject of considerable scientific interest in
addiction and psychiatric research.
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Epidemiological studies on this topic are notoriously dif-
ficult to conduct in a reliable manner since AAS usage is
largely clandestine, partly because the drugs are illegal and
partly because usage tends to take place in closed sub-cul-
tural settings. Despite these problems, we know that the
current use of AAS is relatively widespread in many coun-
tries, including Sweden, which is the site of the current
study. AAS are found in both cities and smaller communi-
ties [3]. The majority of users are male [4,5] and most of
the users begin using the drugs in their teens or early twen-
ties [6].
It has been noted that AAS are often combined with alco-
hol [7] and other drugs of abuse [8] as well as with testo-
sterone releasers, anti-estrogens [2,9] and other
medications [10,11]. The reasons usually given for this are
that the combination both increases the effects of AAS and
decreases various physical and psychological side effects.
Side effects from AAS use reported in men include impo-
tence and infertility due to inhibited endogenous testo-
sterone production. In women, increased virility,
including deepening of the voice, changes in libido and
clitoral enlargement, occurs as a consequence of AAS use
[12]. Other known side effects include atherosclerosis,
hypertension, dilated cardiomyopathy and sudden death.
Psychiatric side effects include irritability, aggressiveness,
mood swings, decreased impulse control and suicidal or
homicidal behaviour [12].
AAS continue to be used, despite knowledge of these
potentially serious side effects. The most commonly
reported motives for using AAS are enhanced performance
in sports, improved physical appearance, increased body
size and aggressiveness, strengthened libido and an
enhanced sense of well-being [3,13-15]. Other justifica-
tions for continuing with AAS include self-fulfilment
accounts, condemnation of condemners (a way of shifting
focus from the user's own deviant acts) and denial of
injury [16].
Most studies regarding motives for using AAS and combi-
nations of drugs are based on athletes. To the best of our
knowledge, there are no studies exploring why and how
non-athletic users have started to use a combination of
drugs. It can therefore be said that the pathways for the
development of mixed abuse are inadequately described.
It has been proposed that AAS abuse can be a gateway to
the use of other drugs of abuse [17-19] and alcohol abuse
[20] but the empirical grounds for these conclusions are
fairly weak.
Although AAS have been studied extensively in recent
years, the perspectives of the users themselves are only
sparsely described, despite in-depth knowledge among
users about the drugs, their effects, their possible side
effects and how they can be combined [6,8,21]. It has also
been reported that AAS users find it problematic that doc-
tors and other healthcare staff have a limited understand-
ing of the issue [15,22-24]. There are thus many reasons
to pay greater attention to the users' own stories about the
development of their abuse patterns and how their use of
different combinations of drugs has developed.
There are a few articles in the scientific literature based on
case reports [16,25-27] describing the development of
AAS use from the user's perspective. Todd [25] performed
in-depth interviews with American weight-lifters concern-
ing AAS use from the athletes' perspective. His conclusion
was that the largest group of AAS users seems to be "aver-
age guys who just want to get bigger and stronger as fast as
they can". Monaghan [16] interviewed 67 bodybuilders
and weight-lifters concerning their motivation for use of
AAS. One important finding was that most AAS users gen-
erally expressed a positive view about the effects of AAS.
Olrich & Ewing [27] interviewed ten men about their
experiences with these drugs. Nearly all of them described
predominantly positive experiences. Their feelings of affir-
mation extended well beyond the walls of the gym and
their narratives suggested feelings of elevated status in
most social environments. The authors suggest that the
users enjoyed benefits linked with the "embodiment of
masculinity" in our culture. The authors therefore stress
that all measures to address AAS abuse, both prevention
and treatment, must be designed on the basis of these
results, since the decision to stop using AAS means forego-
ing experiences of powerfully enhanced masculinity.
Grogan et al. [26] interviewed five women and six men
using snowball sampling. Again, a major finding was that
most of the users in this study reported largely positive
experiences of AAS. The majority felt that moderate use of
AAS was nonproblematic and that the risk of serious side
effects was not a sufficient deterrent to put them off using
the drugs. Information from the healthcare sector regard-
ing AAS was generally disbelieved, particularly since it dif-
fered from their personal experience. The importance of
noting users' largely positive experiences is stressed, and
cooperation with the body building community was
reported as being decisive for the outcome of any pro-
gramme.
In earlier studies, we have described a group of AAS users
from an addiction clinic in terms of their social back-
grounds, current social situation [28] and total drug use
pattern [29]. These studies revealed that AAS abusers often
come from problematic family backgrounds, have a his-
tory of major problems in school, have considerable
social problems in daily life and have common histories
of polysubstance drug use. In the present study, we aim to
complement these data by using in-depth interviews toSubstance Abuse Treatment, Prevention, and Policy 2008, 3:24 http://www.substanceabusepolicy.com/content/3/1/24
Page 3 of 10
(page number not for citation purposes)
focus on the users' own perspectives of their experiences
with AAS.
The aim of the study was thus to let AAS users' own stories
serve as a point of departure for examining the various
consequences of development of drug usage among a
group of people seeking help at an addiction clinic. The
participants were selected to capture as wide a variation as
possible in experiences.
Methods
Sample
This study is based on a total of 36 AAS-users, 34 men and
2 women, who were consecutively included from a psy-
chiatric addiction clinic in Orebro county, central Swe-
den, a county of 275,000 inhabitants. All patients were
attending the addiction clinic to seek help for what they
believed to be AAS-related side effects. The inclusion crite-
ria for participants were that they must: a) be over 16 years
of age, b) be fluent in Swedish, c) have been using non-
prescribed AAS within the last four months, alone or in
combination with other doping agents, d) have been
using AAS for at least four months and e) be under the
care of the addiction clinic where a decision to commence
treatment for their AAS use had been agreed upon follow-
ing an initial clinical assessment. With these criteria for
inclusion, the study included only current users. The
lower limit of four months was chosen to include more
than one AAS cycle, thus indicating regular use.
Selection of subjects
The patients were primarily selected in order to exemplify
variation in the possible combinations of drug use. We
also wanted to include both men and women in order to
illustrate gender-related differences. Another important
criterion for selection was that the narratives should be
detailed and the content richly described. Although the
cutoff point for AAS use was four months, the selected
subjects had a regular use of AAS from nine months to six-
teen years.
Interviews
Prior to the interview, each patient was asked to write
down a description of how their drug use had developed
over the years, including the names of the drugs they used
and when they began using them. The semi-open face-to-
face interviews [30] were conducted by one of the authors
(KS), who has many years of experience in training and
instructing at gyms and who consequently has a good
understanding of the environment with which AAS are
usually associated.
The interview was carried out as a conversation in which
the patient was given considerable freedom on how to tell
their life story [31]. Open-ended questions were used in
the interviews and they were posed in such a way that the
patient was encouraged to relate their experiences as fully
and freely as possible. The order in which the questions
were posed varied and the interviewer tried to adhere as
much as possible to the patient's chosen method of narra-
tion. However, at the end of the interview, the inclusion
of all the areas of interest was checked. The following
areas were covered in the interview:
- childhood, family situation, school experiences
- reason for and situation in which AAS usage was begun
- progress of drug usage
- abuse of other substances
- times at which various substances were first used
- experience of side-effects
- reason for seeking care
The interviews took between one and three hours per
patient. The narratives were written down during the
interview [32] and the material was then compiled into a
personal, chronologically arranged narrative for each
informant [33]. The patients were then given the opportu-
nity to read and comment on these texts and to assess
whether they seemed reasonable and whether they wished
to remove any part. All information that might enable
identification of the person was removed in order to guar-
antee anonymity, and all names used in this article are
therefore fictional. The life stories were formulated as
closely to the language in which the story was told as pos-
sible and in such a way that the informants recognized
them as being accurate and in accordance with their expe-
rience.
Ethical approval
The procedures used in this study have been approved by
the regional ethical vetting board (No.: 538/99) in accord-
ance with the Swedish law concerning approval of medi-
cal research and the patients have given their informed
consent.
Results
Case I – John, 25
The development of early combined drug use starting with AAS
John had a difficult childhood. He felt that he did not
receive any love from his mother since she did not bother
much about him. He was also subjected to sexual abuse by
a relative. He was slender during his teens and bullied by
his classmates. For this reason he began training at a gym
at the age of 16. His goal was to increase both his strengthSubstance Abuse Treatment, Prevention, and Policy 2008, 3:24 http://www.substanceabusepolicy.com/content/3/1/24
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and his body mass. After four years of training, at the age
of 20, one of his gym mates advised him to start taking
AAS to enhance the effects of the training, which he did.
He soon noticed considerable effects on his training and
also enhanced emotional well-being.
After using AAS for some time, he took the advice of some
more experienced gym mates and began taking anti-estro-
gens in order to prevent gynecomastia. He also started
using ephedrine, other bronchodilators and dietary sup-
plements that contained ephedrine in order to make him
more energetic and to enable him to train harder. He felt
both psychologically and physically well when taking
ephedrine and started using this even when not using
AAS. He also began taking testosterone releasers to speed
up his own hormone production. The tough training reg-
imen he now followed led to pain in his muscle insertions
and ligaments, which prompted him to begin also taking
analgesics. John trained regularly and heavily, sometimes
several times a day.
His social interactions became increasingly limited to
other AAS users and his knowledge about the drugs and
their effects grew rapidly. As a child he was very shy, par-
ticularly in relation to girls. He had no contact with girls
but instead developed sexual fantasies that occupied a
great deal of his time and that has continued into adult-
hood. When he was twenty-four years of age, he met a
woman at the gym and they embarked on a relationship,
which was a new experience for him.
In this period of life, the most important thing for him
was training at the gym and his life became increasingly
focused upon medication, diet and training. In order to
train even more, he began using amphetamines; he felt
that this helped him to keep alert during training. His
experience was that amphetamines allowed him to train
even harder. Amphetamines made him feel good mentally
but also led to difficulties in relaxing after training. He
therefore began taking hashish and benzodiazepines to
help him wind down and sleep better. He was now using
amphetamines more frequently because he found them to
be wonderful for recreational use. John had previously
drunk alcohol sparsely but now began using alcohol more
frequently to help him sleep and as recreation at the week-
ends.
Altogether, John was taking fourteen human and veteri-
nary AAS products during a period of five years (oral:
oxymetholone, stanozolol, methandrostenolone and
methenolone acetate; injected: trenbolone acetate, testo-
sterone blends, boldenone, nandrolone esters, methe-
nolone and stanozolol). Throughout the training period
he ate or drank dietary supplements (e.g. protein and var-
ious products containing protein, creatine and ephedra)
with the purpose of enhancing the effects of training.
Initially, John felt the positive effects from his AAS use far
outweighed the negative. He describes increased self-con-
fidence, improved libido and affirmation from both men
and women in his surroundings. However, despite using
various medications to counteract psychological and
physical problems, he experienced more and more nega-
tive effects. He experienced testicle shrinkage, skin lesions
and potency problems. He also began to experience hallu-
cinations, depression, mood swings, aggressiveness and
feelings of persecution. His sexual fantasies also became
more marked.
By the age of 25, after five years of AAS abuse, he was
tested for AAS use at the gym at which he trained. His reg-
imen at this time included nandrolone decanoate and
amphetamine. When the tests proved positive, he was
barred from the gym. John cites this as the stimulus for his
increasing use of amphetamine and alcohol, although he
discontinued both training and AAS. His use of other
drugs of abuse and alcohol worsened, with associated
severe social problems. His company ran out of business,
his girlfriend left him, he failed to pay his rent and he
became destitute. It was in this situation that he sought
help from the addiction clinic, mainly because of his psy-
chological problems.
Case 2 – Joe, 37
The development of late combined drug use starting with AAS
Joe grew up with his biological parents. He was and
remains very close to his mother but was often beaten by
his father, with whom he had a very remote relationship.
Joe describes his upbringing as very strict because of his
father's principles. At school he was often afraid and
teased for being small. However, he completed his school-
ing with top grades. In his early teens, he was prescribed
analgesics for frequent headaches and he has continued to
take them ever since.
At 16 years of age, he started training at the bench press at
a gym and, at the same age, he began drinking alcohol. He
drank a fair amount of alcohol in his late teens but,
because he felt it impaired his training, he decided to
completely quit alcohol in his early twenties. When he
was 21 years of age, he felt he had reached a plateau in his
training. A friend told him to try AAS to enhance his train-
ing. His first course consisted of oral AAS (stanozolol,
oxymetholone and testosterone undecanoate) and the
associated rapid improvement in strength he experienced
prompted him to continue using AAS.
Joe combined AAS with ephedrine and other ephedra
preparations to perk himself up. He also took dietary sup-Substance Abuse Treatment, Prevention, and Policy 2008, 3:24 http://www.substanceabusepolicy.com/content/3/1/24
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plements such as protein powder and other protein sup-
plements, creatine, nutritional replacements and
multivitamins. He learned from other AAS users at the
gym that he could also add anti-estrogens and testoster-
one releasers in order to counteract the unwanted effects
of AAS. He has had to use a number of medications to
counteract what he believed to be side effects from his
AAS use and hard gym training, including analgesics for
pain from over-training, benzodiazepines for insomnia,
and analgesics for headaches and pain in muscles and
joints.
He combined a painkiller containing codeine with water
in a plastic bottle from which he drank continually while
at the gym so that he could train harder and longer.
He also took muscle relaxants immediately after a training
session. Altogether, he used thirteen different AAS medi-
cations during 16 years of AAS abuse (oral: fluoxymester-
one, methandrostenolone, methenolone acetate,
oxymetolone, stanozolol and testosterone undecanoate;
injected: nandrolone esters, stanozolol, several testoster-
one injections, testosterone blends and trenbolone ace-
tate).
He felt that his self-confidence was much improved when
using AAS and he described experiencing better control of
his feelings so that he never felt afraid when he was in a
confrontational situation. He became stronger and gained
weight and felt that his healing capacity was improved.
With time, however, the negative effects increased in
number and severity. He had previously found it easy to
mix with girls. Now he became markedly jealous, had vio-
lent mood swings, outbreaks of aggression and frequent
depression. He also describes an emotional numbness in
relation to others. The physical problems included wear
and tear of his joints, testicular atrophy, gynecomastia,
acne, blood in his urine, kidney pain and infected skin
lesions. The cost of supporting his drug use also continued
to rise, leading to criminal behaviour.
At the age of 30, he began using other drugs of abuse,
including amphetamines and cocaine. Initially, he took
these drugs to increase his ability to train but later he also
started taking them at parties for recreational purposes.
His other drugs of abuse increased rapidly in number and
he began using hashish as well. He sought treatment
because of his narcotics use and for the troubling physical
and psychological problems he believed were derived
from AAS.
Case 3 – Sune, 24
The early development of a complex usage of hormone preparations
Sune had good contact with his father and siblings during
his childhood, but contact with his mother was not as
good and he describes her as having alcohol and psycho-
logical problems. Sune had many friends at school and
has maintained contact with several of them later in life.
He was never bullied or the victim of any kind of violence.
The only problem he recalls from childhood was that he
became aggressive rather easily.
He began training at a gym with some friends at about 15
years of age and, when he was 16, he and some friends
became curious about whether AAS would give supple-
mentary effects. Even before he began trying AAS, Joe had
started using various dietary supplements such as protein
and creatine. The first AAS he bought was a testosterone
product that was to be injected into the buttock. He expe-
rienced clear positive results from this, predominantly as
an increase in weight and strength. He noted, however,
that he became more irritable. He soon began using AAS
more steadily. He used oral AAS (methandrostenolone,
stanozolol), injectible varieties (nandrolone esters, differ-
ent testosterone blends and trenbolone cyclohexylmethyl-
carbonate) and a fluid form of AAS (unknown name) that
could be administered as drops under the tongue.
He later combined AAS with growth hormone and insu-
lin. He took these hormones hoping that this combina-
tion would produce even quicker muscle growth. He also
started using an anti-estrogen so as to reduce the risk of
gynecomastia and testosterone releasers to enhance his
own hormone production. Other substances that were
added later were ephedrine, prohormones, anticatabolics
and testosterone boosters. He was able to train harder and
more frequently while using AAS; however, pain in his
muscle insertions and joints soon developed. He therefore
started taking analgesics in order to be able to train
despite the pain.
When he started using hormones, he also started taking
protein and creatine supplements and various plant ster-
oid compounds. After four years of abuse and 10 different
human steroid products, when he was about 20 years old,
his regimen consisted of AAS drugs (nandrolone ester,
methandrostenolone) in combination with insulin, testo-
sterone releasers and ephedrine.
Sune experienced mainly positive effects from AAS, partic-
ularly in the beginning. He mentioned increased strength
and weight gain above all but also a feeling of attractive-
ness to girls. His sexual drive was considerably increased
after the debut of AAS. Sune was, however, at that time
also troubled by hair growth on his back, skin lesions
between his shoulder and chest musculature, acne,
potency problems, testicular atrophy and a cough that
bothered him particularly after taking testosterone prepa-
rations. He had also suffered serious psychological prob-
lems such as pathological jealousy, mood swings,Substance Abuse Treatment, Prevention, and Policy 2008, 3:24 http://www.substanceabusepolicy.com/content/3/1/24
Page 6 of 10
(page number not for citation purposes)
depression and aggressiveness. Several times he had
become so angry that he smashed up the furniture at his
parents' house. He also attempted to commit suicide.
Sune also sometimes had memory problems and his fixa-
tion with his body was greatly increased. His parents con-
tacted the addiction clinic because they felt their son's
personality had undergone such a radical change.
Case 4 – Bill, 25
The development of body fixation and a complex usage of hormone 
preparations
Bill describes his childhood in glowing terms. He had
good contact with his parents and a younger sister. He was
very active in sports such as football, ice hockey, boxing
and tae kwando while he was growing up. After leaving
home at the age of 15, he stopped these sports and took
up training at a gym instead. His training became so
intense and time-consuming that his schoolwork began to
suffer. He completed his schooling with poor grades.
After a few years of training, he became increasingly
focused on competing in the field of bodybuilding. Bill
had read about AAS and, while he was thinking about
starting to compete, he felt he needed to begin taking AAS
so as to increase his body size, since he believed everyone
in elite level bodybuilding was using AAS. He was 20 years
old when he began taking AAS. The first course consisted
of oral methandrostolone and injections of testosterone
blends. He described the positive effects as including
increased body bulk and strength as well as a powerful
"pump" feeling, particularly in his biceps, when he was
training. He described the feeling when the blood
pumped into a specific muscle as almost orgasmic. He
also described increased libido and significantly
enhanced self-confidence that meant he "felt like a king in
the town". He sought out fights because it gave him a
"good feeling" when others were afraid of him. Bill soon
became preoccupied with his AAS use and began reading
more about preparations, training and AAS. He found
advice that prompted him to start using testosterone
releasers for speeding up his own hormone production.
He had previously begun using dietary supplements such
as protein and creatine and now he added other com-
pounds. His strength and body bulk increased but he
wanted to become even bigger. He now began using a
combination of AAS and other hormone preparations
such as growth hormone, insulin and IGF-1 (Insulin
growth factor 1).
During the four years of AAS use, he used a total of nine
different human and veterinary AAS preparations: oral
AAS consisting of methandrostenolone, stanozolol and
testosterone undecanoate and injectible AAS in the form
of boldenone, nandrolone ester, various testosterone
blends and trenbolone acetate. The whole time that Bill
was training, he used stimulants such as ephedrine and
sometimes bronchodilators to reduce fat and fluid in the
muscle tissues. He has also tested other drugs of abuse
such as amphetamines and hashish at parties and has
used alcohol occasionally.
The second to last course he took, which included nan-
drolone esters, testosterone blends, growth hormone,
insulin, and testosterone releasers, resulted in such a dras-
tic drop in blood sugar level that he was hospitalized. The
first time he sought help at the addiction clinic he
described himself as severely depressed. The reason he
gave was that he had gone from weighing 128 kg to, as he
said, "only 124 kg". He said he could not imagine going
back to his old gym where everyone would see how "small
he had become". In order to gain weight quickly he there-
fore began his last course of AAS. During this course, he
had such drastic physical and psychological problems that
he decided to completely stop using AAS.
Altogether, he suffered a range of physical problems such
as breast development, acne, skin lesions, testicular atro-
phy, reduced libido and fatigue. Psychologically, he felt
depressed, with mood swings, increased aggressiveness,
panic attacks and pronounced body fixation. Sometimes,
under the influence of AAS, he would wander around the
streets of his hometown looking for fights because he felt
himself to be invincible. While using AAS, he developed a
criminal career and was sentenced several times for vari-
ous acts of violent crime.
Case 5 – Irene, 26
The development of the use of enhancing drugs and an extreme body 
fixation
Irene describes her childhood as very problematic. She felt
she was pushed aside as a child because her brothers
always came first. She also experienced sexual harassment
by a close relative and was bullied in school. In her early
teens, she became increasingly fixated with her body, con-
stantly asking others what they thought of it. Irene com-
pleted her schooling with poor grades.
As a teenager she was very active in several sports and at
the age of 17 she began training at a gym as a complement
to her handball training. She felt good and she believed
that her body became more beautiful thanks to the tough
gym training. She soon quit her other sports and decided
to begin gym training to compete in bodybuilding. She
was then convinced that a prerequisite for success in this
sport was the use of AAS, and this led to her AAS debut at
the age of 20. The first course, which lasted three months,
consisted of stanozolol injections. She felt that, once she
had begun using AAS, her body fixation intensified. Dur-
ing the second course, she took not only AAS injectionsSubstance Abuse Treatment, Prevention, and Policy 2008, 3:24 http://www.substanceabusepolicy.com/content/3/1/24
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but also growth hormone (hGH). Her psychological prob-
lems, with mood swings, anxiety and irritation, worsened.
She soon began experiencing more physical problems,
such as clitoris enlargement, hair loss and yellowing of her
skin. In the six years during which she used hormones, she
used four different types of AAS (oral: methandrosten-
olone and stanozolol; injected: methenolone enanthate
and stanozolol). She also took several courses that
included hGH. Early on in her AAS use, she also used
ephedrine and other preparations to reduce subcutaneous
fat and fluid in the muscles (e.g. bronchodilators and a
drug which contained a combination of ephedrine, caf-
feine and aspirin).
Irene trained far harder after starting to take hormones.
Sometimes she would train several times a day, which led
to pains in her muscle insertions. She began taking anal-
gesics in order to continue training despite the pain. She
became much stronger after starting to use AAS, and she
then preferred to train with men. Because she was afraid
of building up fat or retaining fluid, she has only occa-
sionally used dietary supplements over the years and,
when she has done so, has primarily taken protein supple-
ments. She tested creatine but stopped because of weight
gain. Irene was just over 26 when she stopped using AAS
after a final course consisting of oral methenolone acetate,
an ephedra preparation, ephedrine tablets and bron-
chodilators.
Irene describes the positive effects she experienced with
AAS as increased muscle bulk, a harder body and a psy-
chological boost including improved self-confidence.
However, she also notes psychological problems that at
times were considerable, such as jealousy, extreme body
fixation, powerful mood swings, aggressiveness and recur-
rent depression including suicidal fantasies.
She has tried various anti-depressant medications, all of
which she discontinued because she felt they made her
retain fluid. She has also undergone breast enhancement
surgery and her voice became deep. Irene describes how
she became very popular among men and she had an
increased sex drive leading to unfaithfulness. She has lived
in several partnerships but all of them broke up because
of her body fixation and her extreme jealousy, which often
led to maltreatment of partners. Irene sought treatment at
the addiction clinic for her psychological problems, par-
ticularly for her fixation with her body. Before she came to
the clinic she had met several doctors but had not found
them helpful since they knew so little about AAS.
Case 6 – Sonja, 22
The development of oscillating drugs of abuse and AAS use
Sonja grew up with her biological mother and an older
sister. Their parents divorced when the girls were very
young and their mother refused to allow them to meet
their father. Sonja describes her upbringing as slack. Their
mother was described by Sonja as selfish and the girls
were allowed to do as they pleased. Her schooling was rife
with problems and she quit school at the age of fourteen.
She found it difficult to concentrate in class and often
fought with her teachers and with other students. Sonja
became more interested in sports after leaving school and
involved herself in several, including running and swim-
ming.
She travelled overseas to work at the age of 17 and
remained there for one and a half years. After this, she
returned home and met a man who was using other drugs
of abuse. Her contact with him was her gateway into drug
use, and he introduced her to amphetamine. Sonja then
stopped all her sports and instead developed quite a
severe problem with drug use, including heroin and other
opiates, amphetamines and analgesics. Later, she also
included hashish and cocaine.
At the age of 21, she met a man who was using AAS. Under
his influence, she also started to train at the gym. Since she
wanted to have a larger and stronger body, she began
using AAS (oral methandrostenolone), and she discontin-
ued her use of drugs of abuse. Sonja's self-confidence
improved and she felt generally good taking AAS, which
led her to continue with testosterone undecanoate and
stanozolol. While taking this course, she noticed that her
skin became greasier, her hair looked unwashed, and she
had more acne, mood swings and outbreaks of aggression.
She was now training seven days a week at the gym, some-
times twice a day. She began to take dietary supplements
such as protein, creatine, vitamins and sometimes CLA
(Conjugated Linoleic Acid) to keep her weight under con-
trol.
Her aggressiveness worsened after starting AAS use and
she increasingly frequently got into fights in order to find
release for these feelings. She began walking around town
looking for someone to fight with because fighting gave
her a sense of satisfaction. She felt she was truly alive on
these occasions. She bought herself a dog, which she also
beat when it did not behave. During her nine months of
AAS use, she used oral methandienone, testosterone
undecanoate and stanozolol. She also took ephedrine and
clenbuterol before training. After a drug-free period she
once again began taking other drugs of abuse, although in
smaller quantities than before.
She finally stopped taking AAS after encountering prob-
lems such as pain and acne but above all because of her
aggression and suicide attempts. She was also arrested sev-
eral times for her involvement in fights. She had previ-
ously been sentenced for theft but her criminality
increased markedly after she began using AAS. She wasSubstance Abuse Treatment, Prevention, and Policy 2008, 3:24 http://www.substanceabusepolicy.com/content/3/1/24
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then sentenced for drugs of abuse and doping offences.
She sought treatment for her drug problem, which had
increased to include ecstasy, amphetamines, buprenorfin
and benzodiazepines.
Discussion
As far as we are aware, this study is the first in which
patients from an addiction clinic describe the develop-
ment of their multiple drug use including doping agents
(hormone preparations sometimes in combination with
other drugs) from a subjective perspective. A primary find-
ing from the patients' narratives is that the use of AAS can
develop under widely varying conditions in terms of
social background, timing of initiation, development of
multiple drug use, and the associated physical and psy-
chological problems. Despite these significant variations,
certain common features in the patients' stories are dis-
cernible.
Most of the patients in this study describe childhoods
with many problems, including physical or psychological
abuse. Their problems extended into their time at school
and affected both their social and academic achievements.
In an earlier study [28], we found social problems to be
highly overrepresented among AAS users compared with
gym users who were not taking drugs. Negative experi-
ences of school-mates have also been revealed in other
studies [34]. It is important to remember, however, that
some AAS users describe positive childhoods, which
means that there is no straightforward relationship
between upbringing and abuse of AAS [28].
All of the patients in this study began using AAS in associ-
ation with gym training. Most of them were in their late
teens, which tallies with earlier reports [6]. The use of AAS
continued for between nine months and 16 years. This
variation in the duration of AAS use reflects the variations
found in clinical addiction treatment practice. For four of
these patients, AAS was the first drug they had ever used,
while one of them had used alcohol as a first drug and
another had used other drugs of abuse (predominantly
amphetamines). The only gender-related differences we
noticed were that the women used fewer AAS drugs than
the men.
In this study, we found that the participants started gym
training with the addition of dietary supplements and
were later advised to add AAS and other hormones to
enhance the effects of training. To prevent AAS-related
problems and to enhance the AAS effects, they added var-
ious pharmaceuticals, such as ephedrine, testosterone
releasers and anti-estrogens, and also alcohol. Some of
them also later added other drugs of abuse, such as
amphetamine, to further enhance the effects on their
training.
A common reason for taking AAS seems to be the experi-
ence of reaching a plateau in training effects, leading them
to seek possibilities for enhancement. As noted in an ear-
lier study [35], others started AAS to increase body size
and muscle strength. Two patients in our study who began
using AAS because they wished to compete in bodybuild-
ing believed that AAS use was essential for success in this
field. It is of interest that neither of these two patients
mixed the hormones with other drugs of abuse.
For two other informants, use of AAS was soon associated
with use of other hormone preparations, different drugs
of abuse, medications, alcohol, and dietary supplements.
This was, however, not the case for the two who wished to
compete. The reasons given for the increasing numbers of
preparations were to increase the effects of training and
the effects of the AAS or to reduce what were believed to
be side effects of AAS. In a case description by Wilson-
Fearon and Parrot, a male bodybuilder described how he
used a cocktail of drugs before competing [36] and Pope
and Kanayama [24] describe a case of an AAS user starting
to use opioids after getting "pain in his 'delts' from mili-
tary presses".
Several of the patients spoke of a great interest in learning
more about AAS and other hormone preparations. They
readily talked about the underground literature (books,
magazines) and web sites where detailed descriptions
could be found of which preparations and drugs can and,
according to some authors, should be taken with AAS. The
fact that information is sought through these media has
also been noted in a previous study [37].
The knowledge held by many patients about combining
various preparations has clearly become extensive after
taking the drugs for some time. This indicates that they felt
that their careers were dependent on their considerable
knowledge about which drugs can be taken in combina-
tion with AAS. In a study by Grogan et al., this was
reflected in the comment "I know more than my doctor",
particularly when it came to knowledge of the positive
and negative effects of AAS [26].
The subjective experience of AAS varied in type and sever-
ity but was pronounced and associated with considerable
medical and/or psychological problems in all patients.
The most commonly reported physical problems were
changes in sexual potency (increased and/or decreased
libido), skin lesions, testicular atrophy, acne and gyneco-
mastia. Among the commonly reported psychological
side effects were mood swings, aggressiveness, depression,
jealousy and increased fixation with body image. These
problems are commonly reported by AAS users, for exam-
ple on the Swedish anti-doping hot-line [7].Substance Abuse Treatment, Prevention, and Policy 2008, 3:24 http://www.substanceabusepolicy.com/content/3/1/24
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Aggressiveness affected four of the patients (two men and
two women) and prompted three of them to actively seek
out fights. The fourth patient, who already had problems
with aggressiveness before using AAS, was the only one
who reported aggressive breakthroughs as "roid rage". In
a study by Wilson-Fearon, a competitive body builder
described how he had to quit work as a security guard sev-
eral weeks before competing because of problems in con-
trolling his aggressiveness [36].
Pathologically extreme jealousy was a major problem for
four of the patients, causing severe disruptions in their
relationships. Some of the other problems the patients
reported included pain, hair loss or hair growth, clitoris
enlargement, unfaithfulness, suicide attempts or suicidal
thoughts, and emotional numbness. This emotional
numbness was, however, seen as desirable by some
informants since it facilitated fighting.
An important finding in this study is that most of the
patients describe their early experiences of AAS as defi-
nitely positive, perhaps even as the best time of their lives.
Olrich and Ewing showed that three common positive
effects from AAS use were improvement of one's social
status, positive peer recognition and improved vocational
performance (increases in work effectiveness, alertness at
work and confidence at work) [27]. The most common
positive effects described by the patients in this study were
increases in strength, body bulk and self-confidence.
However, the patients also said that, as their AAS use con-
tinued, the negative experiences began to outweigh the
positive experiences and that this development was a nec-
essary prerequisite for seeking treatment.
The results of this study should be viewed in light of the
fact that the sample is small and specifically selected to
represent the wide variations in the development of AAS
abuse that we have noted in our clinical work. It should
be noted that, consequently, quantitative conclusions
couldn't be drawn from this study. In an earlier study [28]
we noted, however, that most AAS users at an addiction
clinic had social problems from their childhoods with
respect to both family and schooling. In another study
[29], we also showed that AAS use is often associated with
use of other drugs of abuse, pharmaceuticals and alcohol.
Conclusion
This study shows the wide variation in patterns of devel-
opment of multiple drug abuse in users of AAS. Earlier
studies have demonstrated that multiple drug use is com-
mon. This study adds information on how this develop-
ment can occur along different paths and for different
reasons, and indicates that AAS can be a gateway to the use
of other drugs of abuse. The stories told by the users pro-
vide information about AAS use from a subjective per-
spective, which can be important when designing
treatment programmes that are adapted to this special
group of patients. By listening to the patients, we can learn
about what can trigger an interest in AAS, how multiple
drugs can be added and what positive and negative effects
can be experienced. This knowledge could help counteract
the low levels of trust that AAS users often show towards
health care providers.
Our objective was not to make broad generalizations but
rather to show the wide variation in the patterns of devel-
opment of preparation use and effects on users of AAS. We
contend that care providers should see their task as two-
fold. Firstly, it is important as a care provider to possess a
high level of general knowledge about AAS use and the
possibility of concomitant drug use in order to instill con-
fidence in the patient at the outset of treatment. Secondly,
it is important that the care provider avoids stereotypical
notions of how abuse usually develops since it can take a
variety of forms and have a variety of outcomes. Good
general knowledge and an interest in the individual
patient's particular life experience are two equally impor-
tant factors in working with AAS users.
The information from this study may also be useful for
policy planning. It is important that the designers of abuse
prevention programmes understand the reasons for start-
ing using AAS in order to develop a fact-based message for
target groups. This information may also be important in
the development of policies concerning detection of
abuse and the development of assistance programmes,
since AAS users often experience a range of highly desira-
ble effects from the drugs and only seek treatment as an
alternative when the negative effects outweigh the positive
effects.
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